ARECOR THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 159 GBX | +0.95% |
|
+0.32% | -12.88% |
| 21/05 | Transcript : Arecor Therapeutics plc - Special Call | |
| 20/05 | Arecor Therapeutics plc Announces Its Ultra-Concentrated, Ultra-Rapid Acting Insulins | CI |
Presenter SpeechSarah Howell (Executives)Okay. So good morning, everybody. And it's a pleasure...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Arecor Therapeutics plc is a United Kingdom-based globally focused biopharmaceutical company. The Company, by applying its technology platform, Arestat, is developing an internal portfolio of products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver therapeutic products. Its portfolio includes AT247 - Ultra-Rapid Acting Insulin and AT278 - Ultra-Concentrated Ultra-Rapid Acting Insulin. Its lead product, AT247, is an Arestat enabled formulation of insulin designed to accelerate insulin absorption post injection, to enable effective management of blood glucose levels for people living with diabetes, particularly around difficult to manage mealtimes. The Company's AT278 is an ultra-concentrated novel formulation of ultra-rapid acting insulin. Its subsidiary, Tetris Pharma Ltd, has a portfolio of injectable products including Ogluo, which is a ready-to-use glucagon for emergency use to treat hypoglycemia.
Calendar
28/06/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.59
GBP
Average target price
5.037
GBP
Spread / Average Target
+216.77%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.88% | 61.96M | |
| +43.36% | 54.64B | |
| -5.31% | 39.92B | |
| +37.52% | 38.82B | |
| +14.75% | 26.86B | |
| -12.56% | 26.22B | |
| -22.45% | 18.78B | |
| +0.04% | 12.16B | |
| +25.12% | 12.21B | |
| +26.04% | 11.94B |
- Stock Market
- Equities
- AREC Stock
- News Arecor Therapeutics plc
- Transcript : Arecor Therapeutics plc, 2023 Earnings Call, May 16, 2024
